Centene Corp
NYSE:CNC
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
57.46
80.41
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Centene Corp
Price/Premiums
Price to Premiums
| Market Cap | Price/Premiums | ||||
|---|---|---|---|---|---|
| US |
|
Centene Corp
NYSE:CNC
|
30.6B USD | 0 | |
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
560.3B USD | 1.4 | |
| US |
A
|
Anthem Inc
LSE:0HG8
|
105.1B USD | 0.6 | |
| US |
|
Elevance Health Inc
NYSE:ELV
|
93.2B USD | 0.5 | |
| US |
|
Humana Inc
NYSE:HUM
|
35.7B USD | 0.3 | |
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
16.8B USD | 0 | |
| US |
|
Healthequity Inc
NASDAQ:HQY
|
9B USD | 0 | |
| BR |
|
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
22.7B BRL | 0 | |
| US |
M
|
Magellan Health Inc
F:MAH1
|
2.2B EUR | 0 | |
| US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
1.7B USD | 0 | |
| US |
|
Progyny Inc
NASDAQ:PGNY
|
1.3B USD | 0 |
Price/Premiums Forward Multiples
Forward Price/Premiums multiple is a version of the Price/Premiums ratio that uses forecasted gross premiums earned for the Price/Premiums calculation. 1-Year, 2-Years, and 3-Years forwards use gross premiums earned forecasts for 1, 2, and 3 years ahead, respectively.
You don't have any saved screeners yet
